作为多种疾病疫苗的多功能平台的MS2病毒样颗粒:一项审查
Guodong Zhou1,2, Zhili Luo1, Zhihui Zhang2,3
1College of Agriculture and Biology, Liaocheng University, Liaocheng, Shandong, China.
Frontiers in immunology
|September 19, 2025
概括
MS2菌体外层蛋白自组装成用于疫苗的病毒样颗粒 (VLP). 这些VLP可以显示抗原并携带RNA,在免疫疗法和诊断中显示出广泛的潜力.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- 在MS2菌体上,外层蛋白会自组合成类似病毒的粒子 (VLP).
- 这些VLP具有免疫性,可以用于抗原显示和RNA包装.
- 虚拟临床平台为疫苗和诊断开发提供了一个多功能平台.
研究的目的:
- 提供MS2菌体外蛋白VLP基础的疫苗研究的全面审查.
- 突出MS2 VLP在各种免疫疗法中的进步和应用.
- 作为未来VLP疫苗开发的参考.
主要方法:
- 基因工程的MS2外套蛋白质为N端显示.
- 外源序列与MS2 pac位点的融合用于选择性RNA整合.
- 在疫苗开发中对MS2 VLP应用现有文献的审查.
主要成果:
- MS2 VLPs可以显示高达91个氨基酸的抗原.
- 工程MS2 VLPs促进了对异种RNA的选择性结合.
- 在病毒,寄生虫,甲状腺炎和癌症免疫疗法中有明显的应用.
结论:
- MS2菌体外蛋白VLP是疫苗开发的一个有前途的平台.
- 它们的多功能性支持各种治疗领域的应用,包括癌症免疫疗法.
- 对MS2 VLP的持续研究将推动疫苗和诊断技术的发展.
相关概念视频
Microorganisms in Medicine and Therapeutics
987
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
987
Viral Recombination
24.9K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.9K


